A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: HER2-positive Breast Cancer
Interventions: OTHER: Acquisition of blood samples and tumour tissue samples (biopsies)
Sponsor: King's College London
Collaborators: Guy's and St Thomas' NHS Foundation Trust|Brighton and Sussex University Hospitals NHS Trust